Phase 1 trial (Small human trial to evaluate safety and immunogenicity)
Phase 2 trial (Larger human trial to evaluate safety and efficacy)
Phase 3 trial (Definitive assessment of safety and efficacy in a large population)
Phase 4 trial (Determine safety over time; evaluate other uses)
Support for international clinical studies
Support for clinical programs (information only)
DMID Clinical Research Policies and Procedures
Last Updated September 12, 2012